Sea Crest Wealth Management, LLC Harvard Bioscience Inc Transaction History

Sea Crest Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$1.93 - $4.59 $1,544 - $3,672	-800 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$3.03 - $5.0 $2,424 - $4,000	-800 Reduced 50.0%	800 $3,000
Q3 2018 Nov 14, 2018	BUY	$5.0 - $6.65 $4,000 - $5,320	800 Added 100.0%	1,600 $8,000
Q4 2017 Feb 02, 2018	BUY	$3.08 - $3.8 $2,464 - $3,040	800	800 $3,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.